SpaceX closed below $135 per share this week, marking the first time the company's secondary-market price has breached the level set during its initial public offering. The stock traded flat in Thursday premarket after settling just above $135 on Wednesday, completing a round trip that took less than sixty days from debut to repricing.
The $135 level was established last month when Space Exploration Technologies offered shares to institutional and accredited investors in what amounted to a controlled distribution rather than a traditional exchange listing. The vehicle is simultaneously a launch-services provider with NASA and Defense Department contracts and an AI infrastructure play via Starlink satellite bandwidth. That dual mandate creates valuation tension: aerospace primes trade at 12x to 15x EBITDA, while AI-adjacent infrastructure commands 25x to 40x. The market appears to be resolving that tension downward.
Historical data from Renaissance Capital shows that 48% of IPOs with valuations above $1 billion trade below their offer price within the first year, with median time to recovery at 22 months. Meta Platforms fell 53% below its $38 IPO price before beginning a multi-year climb. Uber traded below $45 for eighteen months. The pattern is mechanical: early buyers lock in allocations at a known price, then reassess against public comps and forward earnings once the scarcity premium dissipates. SpaceX is no exception to that clearing process.
What separates SpaceX is the opacity. The company releases no quarterly financials, no revenue guidance, and no margin breakouts between launch services and Starlink subscriptions. Allocators are pricing a $200 billion enterprise value—roughly 4x Boeing's market cap—using third-party Starlink subscriber estimates and disclosed NASA contract values. That information asymmetry widens the bid-ask spread and increases volatility during sector rotations. The recent flight to quality out of speculative growth has compressed multiples across aerospace and satellite plays, and SpaceX is experiencing that repricing without the disclosure infrastructure to stabilize sentiment.
Operators should track two items in the next 90 days: whether SpaceX provides any voluntary disclosure on Starlink's unit economics, and whether secondary-market volume picks up as early investors approach lock-up expiration. Family offices with exposure should also monitor NASA's Artemis mission schedule; any delay in the Lunar Gateway contract would remove a $3 billion revenue anchor and likely push the stock lower. The $135 level now functions as technical resistance rather than psychological support.
The stock is doing what 48% of major debuts do, which is find a post-offering equilibrium somewhere below the price underwriters could command in a controlled book.